Amyloid Aggregation in Alzheimer’s and Parkinson’s Diseases
Several studies suggest that protein aggregation in the brain leads to neurodegenera-tive diseases. Two examples of this are seen in the neuropathological hallmarks of Parkinson’s disease (PD) and Alzheimer’s disease (AD) in the form of a-synuclein (a-syn) and amyloid-beta (Ab) plaques, respectively. However, an overlap of these pa-thologies has been observed in more than 50% of AD cases. This res
